Literature DB >> 24117229

Next-generation sequencing of formalin-fixed, paraffin-embedded tumor biopsies: navigating the perils of old and new technology to advance cancer diagnosis.

Gary J Latham1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24117229     DOI： 10.1586/14737159.2013.845090

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN： 1473-7159            Impact factor:   5.225


× No keyword cloud information.
  5 in total

Review 1.  Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics.

Authors:  Saumya Pant; Russell Weiner; Matthew J Marton
Journal:  Front Oncol       Date:  2014-04-17       Impact factor: 6.244

2.  Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.

Authors:  Ashish Choudhary; Elizabeth Mambo; Tiffany Sanford; Michael Boedigheimer; Brian Twomey; Joseph Califano; Andrew Hadd; Kelly S Oliner; Sylvie Beaudenon; Gary J Latham; Alex T Adai
Journal:  BMC Med Genomics       Date:  2014-11-14       Impact factor: 3.063

3.  Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.

Authors:  Wendy W J de Leng; Christa G Gadellaa-van Hooijdonk; Françoise A S Barendregt-Smouter; Marco J Koudijs; Ies Nijman; John W J Hinrichs; Edwin Cuppen; Stef van Lieshout; Robert D Loberg; Maja de Jonge; Emile E Voest; Roel A de Weger; Neeltje Steeghs; Marlies H G Langenberg; Stefan Sleijfer; Stefan M Willems; Martijn P Lolkema
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

4.  Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.

Authors:  Jeffrey Houghton; Andrew G Hadd; Robert Zeigler; Brian C Haynes; Gary J Latham
Journal:  J Vis Exp       Date:  2016-04-11       Impact factor: 1.355

5.  Design, Optimization, and Multisite Evaluation of a Targeted Next-Generation Sequencing Assay System for Chimeric RNAs from Gene Fusions and Exon-Skipping Events in Non-Small Cell Lung Cancer.

Authors:  Richard A Blidner; Brian C Haynes; Stephen Hyter; Sarah Schmitt; Ziyan Y Pessetto; Andrew K Godwin; Dan Su; Patrick Hurban; Léon C van Kempen; Maria L Aguirre; Shobha Gokul; Robyn D Cardwell; Gary J Latham
Journal:  J Mol Diagn       Date:  2018-12-04       Impact factor: 5.341
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.